Sabinsa Corporation, has been awarded the Thomas Alva Edison Patent Award for 2005 in the Enabling Technology/Small Company category for US Patent 6,849,645 for the invention titled “Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives”. The Thomas Alva Edison Patent Awards, which recognizes the most revolutionary product innovations and important scientific breakthroughs originating in New Jersey, was presented at the Research & Development Council's annual fall dinner on November 3, 2005, at the North Maple Inn, Basking Ridge. Sabinsa Corporation also received this award in 2004 for its U.S. Patent #5,804,596 for the invention titled, “Method of preparing a forskolin composition for use in promoting lean body mass and treating mood disorders”. 

Companies throughout New Jersey are invited to submit patents for consideration for the Thomas Alva Edison Patent Awards.  Each patent is reviewed thoroughly by the Council, which is comprised of senior representatives from industry, academia and government.  Winners are then chosen based on their exceptional merit. 

The Research and Development Council of New Jersey, which has instituted this award is a non-profit organization dedicated to cultivating an environment that supports the advancement of research and development throughout New Jersey.  The Council is comprised of senior representatives from industry, academia and government. In fact, many R&D Council members represent today's Fortune 100 companies. 

For more information visit www.rdnj.org